This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Mammography World Markets

7.1 Global Market for Mammography Equipment 113

7.1.1 Global Market for Full-Field Digital Mammography Systems 114

7.1.2 Leading Vendors in Mammography Sector 115

7.2 U.S. Market for Full-Field Digital Mammography 115

7.2.1 Decline in the Number of Mammography Facilities and Units in the U.S. 116

7.2.2 Growth in Number of Digital Mammography Facilities in the U.S. 117

7.3 Rest of the World Market for Digital Mammography 118

7.4 Mammography Systems Market in Europe 119

8. Profiles of Market Leaders in Mammography 1218.1 Fujifilm U.S.A., Inc. 1218.1.1 Amulet f/Amulet s 1218.1.2 Fuji's 3D Mammography Viewer 1218.2 GE Healthcare Ltd. 1228.2.1 SenoBright 1228.2.2 Senographe Essential 1228.2.3 Senographe Essential e 1238.2.4 Senographe Care 1238.2.5 Senographe DS 1248.2.6 GE's Mammography Workstations 1248.3 Hologic, Inc. 1248.3.1 Selenia Dimension 3D 1258.3.2 Selenia Dimensions 2D 1258.3.3 SecurView 1268.3.4 SecurXchange Archiving Solution 1268.3.5 M-Series (Analog) 1268.3.5.1 StereoLoc 1268.3.5.2 Affinity 1278.4 Philips Healthcare 1278.4.1 MammoDiagnost (Analog) 1278.4.2 MammDiagnost DR 1288.4.3 MammoDiagnost with PCR Eleva 1288.5 Siemens Healthcare 1288.5.1 Mammomat 3000 Nova 1298.5.2 Mammomat 1000 1298.5.3 Syngo MammoReport 129

Appendix 1: Timeline of Advances Against Breast Cancer 130

Appendix 1.1: Timeline 130

Appendix 2: A Woman's Guide to Breast Cancer 138

Appendix 2.1: Breast Biopsy 138

Appendix 2.2: Staging of Breast Cancer 139

Appendix 2.3: Treatment Options 141

Appendix 3: A Women's Guide to Mammograms 146

Appendix 4: A Voice against Screening Mammography 151

Appendix 5: Performance of Tomosynthesis in Different Breast Compositions and Lesion Types 153

Appendix 5.1: Improved Sensitivity 154

Appendix 5.2: Reduced Recall Rate 154

Appendix 5.3: Greater Performance Using Two-View Tomosynthesis 155

Appendix 5.4: Performance of Tomosynthesis in Different Breast Compositions and Lesion Types 155

Appendix 5.5: Performance in Calcifications, Masses and Distortions 155

Appendix 5.6: Performance in Invasive and Non-Invasive Breast Cancers 156

Appendix 5.7: Performance in Fatty and Dense Breasts 156

5 of 14

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs